Is Mounjaro a Daily or Weekly Injection? Understanding Your Treatment Schedule

Last reviewed: July 11, 2026

Last updated: July 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Mounjaro (tirzepatide) is administered as a subcutaneous injection once every seven days, not daily. This weekly schedule has made it one of the most popular GLP-1 receptor agonist medications for weight management and type 2 diabetes control.

How Often Do You Inject Mounjaro?

Mounjaro requires a single injection once per week, typically given on the same day each week for consistency. Patients self-administer the pen injection at home into the abdomen, thigh, or upper arm. The once-weekly schedule differs significantly from older insulin therapies that required daily or multiple daily injections, making treatment adherence easier for most patients.

The tirzepatide formulation in Mounjaro is designed for sustained release over seven days, meaning one injection covers your entire week. This extended-duration mechanism allows steady levels of the medication in your bloodstream without daily dosing burdens. Many patients find this schedule fits naturally into their routine—some choose every Monday morning or Friday evening as their injection day.

Starting Dose and Dose Escalation Schedule

Mounjaro treatment begins with a 2.5 mg starting dose, then increases every four weeks based on your tolerance and weight loss response. The typical progression moves from 2.5 mg to 5 mg to 7.5 mg, with a maximum maintenance dose of 15 mg weekly. This gradual escalation allows your body to adjust to the medication and reduces nausea and gastrointestinal side effects.

Your prescribing provider adjusts the dose level at four-week intervals, though some patients may need longer to tolerate increases. The dose ladder exists to find your optimal therapeutic level—the amount that produces meaningful weight loss while keeping side effects manageable. Even at starting doses, many patients experience appetite suppression and reduced food cravings within the first few days.

Tirzepatide Injection Timing and Storage Tips

You can inject Mounjaro at any time of day, with or without food—timing flexibility is one of the medication's conveniences. Most patients choose a consistent day and time to build the habit, such as every Wednesday morning before breakfast. The injection takes only seconds, and you can rotate injection sites to prevent lipohypertrophy (thickening of fatty tissue).

Mounjaro pens must be stored in a refrigerator between 2°C and 8°C before first use, then kept at room temperature (up to 25°C) after you start using them. Once opened, pens remain stable for 28 days at room temperature. If you travel or go on vacation, the pens fit easily into a portable cooler or insulated medication bag, allowing you to maintain your weekly schedule without interruption.

PlexusDx Compounded Tirzepatide: Same Weekly Schedule, Greater Accessibility

PlexusDx provides compounded tirzepatide injections with the identical weekly dosing schedule as brand Mounjaro, starting at $249 per month flat. Unlike brand medication pricing that varies by dosage tier, PlexusDx's flat monthly rate means your dose may increase during treatment, but your price stays the same. All formulations come from licensed 503A compounding pharmacies that meet rigorous pharmaceutical standards and state oversight.

Compounded tirzepatide offers several advantages: no insurance requirements, HSA/FSA eligibility, and availability across all 50 states. PlexusDx also pairs tirzepatide therapy with the optional Precision Peptide Genetic Test ($99 add-on after your first month), which maps your genetic predispositions across 14 metabolic pathways and 49 peptides to personalize your treatment plan. Your weekly injection routine remains straightforward—same schedule, more personalized science.

Weekly vs. Daily: Why Once-Weekly Beats Daily Dosing

The shift from daily to weekly GLP-1 therapy represents a major improvement in patient convenience and adherence rates. Daily pills require 365 decisions per year; weekly injections require only 52. This reduction in decision fatigue translates to fewer missed doses and more consistent weight loss results over months and years.

Clinical data shows that patients on weekly GLP-1 regimens report higher medication adherence and better long-term outcomes than those on daily formulations. The sustained therapeutic levels from once-weekly dosing also produce more stable appetite suppression and metabolic effects. For patients balancing work, family, and health goals, the weekly schedule removes a significant barrier to consistent treatment success.

Common Questions About Your Weekly Injection Routine

Many patients ask whether missing a dose requires doubling the next week's injection—the answer is no. If you miss your weekly dose, simply inject as soon as you remember, then resume your normal schedule the following week. Doubling doses increases side effects without additional benefit and is not recommended by prescribers.

Some patients wonder if they can adjust their injection day if their schedule changes. Yes, you can shift your injection day forward or backward, but try to maintain seven-day intervals as much as possible. PlexusDx providers can discuss scheduling flexibility during your initial consultation and help you find the timing that best fits your lifestyle.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is Mounjaro a daily injection or weekly?

Mounjaro is a weekly injection given once every seven days. You choose a consistent day each week and inject yourself at home. This weekly schedule makes it simpler than daily medications and improves adherence to treatment.

What happens if I miss my weekly Mounjaro injection?

If you miss a dose, inject as soon as you remember within three days. Resume your normal schedule the following week—do not double-dose. Missing occasional doses may slow your weight loss progress, but catching up quickly minimizes impact.

Can I use compounded tirzepatide from PlexusDx with the same weekly schedule?

Yes. PlexusDx compounded tirzepatide injections follow the identical once-weekly dosing schedule as brand Mounjaro, starting at $249/month flat. Your dose may increase, but your price won't—plus no insurance is needed and HSA/FSA funds apply.

How quickly do you see weight loss results on weekly tirzepatide injections?

Most patients notice reduced appetite within the first week, with measurable weight loss appearing in weeks 2–4. Clinical trials show average weight loss of 15–20% over six months at therapeutic doses. Your individual results depend on dose level, diet, activity, and genetic factors that PlexusDx's Precision Peptide test can help identify.

Does the Precision Peptide Genetic Test help with tirzepatide success?

No — the Precision Peptide Genetic Test does not predict your response to Mounjaro or any specific medication. It analyzes pathway-level variants (GLP1R (rs6923761), GIPR (rs1800437), and FTO (rs9939609)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Injection Mounjaro
• Mounjaro Injection Price
• Mounjaro Injection Sites
• Mounjaro Injection Site

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.